Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA: A Cancer Journal for Clinicians 2015; 65:5-29.
   PubMed Web of Science ®Google Scholar
• Davies L, Welch H. Increasing Incidence of Thyroid Cancer in the United States, 1973–2002. JAMA 2006; 18:2164-7; http://dx.doi.org/10.1001/jama.295.18.2164
   Web of Science ®Google Scholar
• Shoup M, Stojadinovic A, Nissan A, Ghossein RA, Freedman S, Brennan MF, Shah JP, Shaha AR. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg 2003; 197:191-7; PMID:12892796; http://dx.doi.org/10.1016/S1072-7515(03)00332-6
   PubMed Web of Science ®Google Scholar
• Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. CELL 2009; 136:629-41; PMID:19239885; http://dx.doi.org/10.1016/j.cell.2009.02.006
   PubMed Web of Science ®Google Scholar
• Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet 2009; 10:155-9; PMID:19188922; http://dx.doi.org/10.1038/nrg2521
   PubMed Web of Science ®Google Scholar
• Yuan SX, Yang F, Yang Y, Tao QF, Zhang J, Huang G, Yang Y, Wang RY, Yang S, Huo XS, et al. Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy. Hepatology 2012; 56:2231-41; PMID:22706893; http://dx.doi.org/10.1002/hep.25895
   PubMed Web of Science ®Google Scholar
• Tanos V, Ariel I, Prus D, De-Groot N, Hochberg A. H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium. Int J Gynecol Cancer 2004; 14:521-5; PMID:15228427; http://dx.doi.org/10.1111/j.1048-891x.2004.014314.x
   PubMed Web of Science ®Google Scholar
• Lin R, Maeda S, Liu C, Karin M, Edgington TS. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. ONCOGENE 2007; 26:851-8; PMID:16878148; http://dx.doi.org/10.1038/sj.onc.1209846
   PubMed Web of Science ®Google Scholar
• Kamel MM, Matboli M, Sallam M, Montasser IF, Saad AS, El-Tawdi AH. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma. Transl Res 2016; 168:134-45; PMID:26551349; http://dx.doi.org/10.1016/j.trsl.2015.10.002
   PubMed Web of Science ®Google Scholar
• Yang Z, Guo X, Li G, Shi Y, Li L. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges. Cancer Lett 2016; 371:62-70; PMID:26577810; http://dx.doi.org/10.1016/j.canlet.2015.11.011
   PubMed Web of Science ®Google Scholar
• Jendrzejewski J, Thomas A, Liyanarachchi S, Eiterman A, Tomsic J, He H, Radomska HS, Li W, Nagy R, Sworczak K, et al. PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by ModulatingS100A4 Gene Expression. J Clin Endocrinol Metab 2015; 100:E1370-7; PMID:26274343; http://dx.doi.org/10.1210/jc.2015-2247
   PubMed Web of Science ®Google Scholar
• Jendrzejewski J, He H, Radomska HS, Li W, Tomsic J, Liyanarachchi S, Davuluri RV, Nagy R, de la Chapelle A. The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proc Natl Acad Sci 2012; 109:8646-51; http://dx.doi.org/10.1073/pnas.1205654109
   PubMed Web of Science ®Google Scholar
• Lan X, Sun W, Zhang P, He L, Dong W, Wang Z, Liu S, Zhang H. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance. Tumor Biol 2016; 37:6117-23; http://dx.doi.org/10.1007/s13277-015-4461-4
   PubMed Web of Science ®Google Scholar
• Prasad NB, Kowalski J, Tsai H, Talbot K, Somervell H, Kouniavsky G, Wang Y, Dackiw APB, Westra WH, Clark DP, et al. Three-Gene Molecular Diagnostic Model for Thyroid Cancer. Thyroid 2012; 22:275-84; PMID:22280184; http://dx.doi.org/10.1089/thy.2011.0169
   PubMed Web of Science ®Google Scholar
• Chiappetta G, Ferraro A, Vuttariello E, Monaco M, Galdiero F, De Simone V, Califano D, Pallante P, Botti G, Pezzullo L, et al. HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias. Eur J Cancer 2008; 44:1015-21; PMID:18375116; http://dx.doi.org/10.1016/j.ejca.2008.02.039
   PubMed Web of Science ®Google Scholar
• Pallante P, Sepe R, Puca F, Fusco A. High mobility group A proteins as tumor markers. Fron Med 2015; 2:15; PMID:25729750; http://dx.doi.org/10.3389/fmed.2015.00015
   Web of Science ®Google Scholar
• Ayoubi TA, Jansen E, Meulemans SM, Van de Ven WJ. Regulation of HMGIC expression: an architectural transcription factor involved in growth control and development. Oncogene 1999; 18:5076-87; PMID:10490844; http://dx.doi.org/10.1038/sj.onc.1202881
   PubMed Web of Science ®Google Scholar
• Berlingieri MT, Manfioletti G, Santoro M, Bandiera A, Visconti R, Giancotti V, Fusco A. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol 1995; 15:1545-53; PMID:7862147; http://dx.doi.org/10.1128/MCB.15.3.1545
   PubMed Web of Science ®Google Scholar
• Cleynen I, Van de Ven WJ. The HMGA proteins: a myriad of functions (Review). Int J Oncol 2008; 32:289-305; PMID:18202751
   PubMed Web of Science ®Google Scholar
• Vallone D, Battista S, Pierantoni GM, Fedele M, Casalino L. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. Embo J 1997; 16(17):5310–5321; PMID:9311991
   PubMed Web of Science ®Google Scholar
• Belge G, Meyer A, Klemke M, Burchardt K, Stern C, Wosniok W, Loeschke S, Bullerdiek J. Upregulation ofHMGA2 in thyroid carcinomas: A novel molecular marker to distinguish between benign and malignant follicular neoplasias. Genes, Chromosomes and Cancer 2008; 47:56-63; http://dx.doi.org/10.1002/gcc.20505
   PubMed Web of Science ®Google Scholar
• Chiappetta G, Bandiera A, Berlingieri MT, Visconti R, Manfioletti G, Battista S, Martinez-Tello FJ, Santoro M, Giancotti V, Fusco A. The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene 1995; 10:1307-14; PMID:7731681
   PubMed Web of Science ®Google Scholar
• Jin L, Lloyd RV, Henry MR, Erickson LA, Sebo TJ, Rumilla KM, Zhang J. The diagnostic utility of combination of HMGA2 and IMP3 qRT-PCR testing in thyroid neoplasms. Appl Immunohistochem Mol Morphol 2015; 23:36-43; PMID:25356939; http://dx.doi.org/10.1097/PAI.0000000000000031
   PubMedGoogle Scholar
• Jin L, Lloyd RV, Nassar A, Lappinga PJ, Sebo TJ, Swartz K, Seys AR, Erickson-Johnson MR, Roth CW, Evers BR, et al. HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR. Diagn Mol Pathol 2011; 20:71-80; PMID:21532495; http://dx.doi.org/10.1097/PDM.0b013e3181ed784d
   PubMedGoogle Scholar
• Barros-Filho MC, Marchi FA, Pinto CA, Rogatto SR, Kowalski LP. High Diagnostic Accuracy Based onCLDN10 ,HMGA2 , andLAMB3 Transcripts in Papillary Thyroid Carcinoma. The J Clin Endocrinol Metab 2015; 100:E890-9; PMID:25867809; http://dx.doi.org/10.1210/jc.2014-4053
   PubMed Web of Science ®Google Scholar
• Nagar S, Ahmed S, Peeples C, Urban N, Boura J, Thibodeau B, Akervall J, Wilson G, Long G, Czako P. Evaluation of genetic biomarkers for distinguishing benign from malignant thyroid neoplasms. Am J Surg 2014; 207:596-601; PMID:24713092; http://dx.doi.org/10.1016/j.amjsurg.2013.06.012
   PubMed Web of Science ®Google Scholar
• Xia YY, Yin L, Tian H, Guo WJ, Jiang N, Jiang XS, Wu J, Chen M, Wu JZ, He X. HMGA2 is associated with epithelial-mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma. Onco Targets Ther 2015; 8:169-76; PMID:25653540; http://dx.doi.org/10.2147/OTT.S74397
   PubMed Web of Science ®Google Scholar
• Xia YY, Yin L, Jiang N, Guo WJ, Tian H, Jiang XS, Wu J, Chen M, Wu JZ, He X. Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells. Biochem Biophys Res Commun 2015; 463:357-63; PMID:26025649; http://dx.doi.org/10.1016/j.bbrc.2015.05.068
   PubMed Web of Science ®Google Scholar
• Damanakis AI, Eckhardt S, Wunderlich A, Roth S, Wissniowski TT, Bartsch DK, Di Fazio P. MicroRNAs let7 expression in thyroid cancer: correlation with their deputed targets HMGA2 and SLC5A5. J Cancer Res Clin 2016; 142:1213-20; http://dx.doi.org/10.1007/s00432-016-2138-z
   PubMed Web of Science ®Google Scholar
• Rice SJ, Lai SC, Wood LW, Helsley KR, Runkle EA, Winslow MM, Mu D. MicroRNA-33a Mediates the Regulation of High Mobility Group AT-Hook 2 Gene (HMGA2) by Thyroid Transcription Factor 1 (TTF-1/NKX2-1). J BIOL CHEM 2013; 288:16348-60; PMID:23625920; http://dx.doi.org/10.1074/jbc.M113.474643
   PubMed Web of Science ®Google Scholar
• Wu ZY, Wang SM, Chen ZH, Huv SX, Huang K, Huang BJ, Du JL, Huang CM, Peng L, Jian ZX, et al. MiR-204 regulates HMGA2 expression and inhibits cell proliferation in human thyroid cancer. Cancer Biomark 2015; 15:535-42; PMID:26406941; http://dx.doi.org/10.3233/CBM-150492
   PubMed Web of Science ®Google Scholar
• Ma C, Nong K, Zhu H, Wang W, Huang X, Yuan Z, Ai K. H19 promotes pancreatic cancer metastasis by derepressing let-7s suppression on its target HMGA2-mediated EMT. Tumour Biol 2014; 35:9163-9; PMID:24920070; http://dx.doi.org/10.1007/s13277-014-2185-5
   PubMed Web of Science ®Google Scholar
• Deng L, Yang SB, Xu FF, Zhang JH. Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge. J Exp Clin Cancer Res 2015; 34:18; PMID:25884472; http://dx.doi.org/10.1186/s13046-015-0136-7
   PubMed Web of Science ®Google Scholar
• The Gene Ontology (GO) project in 2006. NUCLEIC ACIDS RES 2006; 34:D322-6.
   PubMed Web of Science ®Google Scholar
• Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25:25-9.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res 2004; 32:D277-80; PMID:14681412; http://dx.doi.org/10.1093/nar/gkh063
   PubMed Web of Science ®Google Scholar
• Yi M, Horton JD, Cohen JC, Hobbs HH, Stephens RM. WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data. BMC BIOINFORMATICS 2006; 7:30; PMID:16423281; http://dx.doi.org/10.1186/1471-2105-7-30
   PubMed Web of Science ®Google Scholar
• Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C, Romero R. A systems biology approach for pathway level analysis. Genome Res 2007; 17:1537-45; PMID:17785539; http://dx.doi.org/10.1101/gr.6202607
   PubMed Web of Science ®Google Scholar
• Dupuy D, Bertin N, Hidalgo CA, Venkatesan K, Tu D, Lee D, Rosenberg J, Svrzikapa N, Blanc A, Carnec A, et al. Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans. Nat Biotechnol 2007; 25:663-8; PMID:17486083; http://dx.doi.org/10.1038/nbt1305
   PubMed Web of Science ®Google Scholar
• Jia H, Osak M, Bogu GK, Stanton LW, Johnson R, Lipovich L. Genome-wide computational identification and manual annotation of human long noncoding RNA genes. RNA 2010; 16:1478-87; PMID:20587619; http://dx.doi.org/10.1261/rna.1951310
   PubMed Web of Science ®Google Scholar